curasafehealthcare.com
  • Home
  • About
  • Services
  • Therapeutic Areas
  • Careers
  • Latest News
  • Contact Us
Select Page

The Combined First Trimester Screening

by palligoelme@gmail.com | Jun 11, 2025 | Clinical Trials

​ Conditions: Preeclampsia (PE); Fetal Growth Restriction; Congenital Abnormalities; Preterm Labor; Intrauterine Fetal Demise; Genetics Syndrome; Pregnancy Overdue – Week 41+6 Sponsors: Institute of Health Information and Statistics of the Czech Republic;...

Study of Deucravacitinib for Refractory Adults With Dermatomyositis/Juvenile Dermatomyositis

by palligoelme@gmail.com | Jun 11, 2025 | Clinical Trials

​ Conditions: Myositis; Dermatomyositis Interventions: Drug: Deucravacitinb Sponsors: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Not yet recruiting Conditions: Myositis; Dermatomyositis Interventions: Drug: Deucravacitinb Sponsors:...

Treating Basal and Squamous Cell Carcinomas With Fractional Laser and Tirbanibulin Ointment

by palligoelme@gmail.com | Jun 11, 2025 | Clinical Trials

​ Conditions: Keratinocyte Carcinoma; Basal Cell Carcinomas; Squamous Cell Carcinoma; Skin Cancer Interventions: Drug: Tirbanibulin ointment 1%; Device: non-ablative fractional laser Sponsors: Bruce Robinson, MD Recruiting Conditions: Keratinocyte Carcinoma; Basal...

ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis

by palligoelme@gmail.com | Jun 10, 2025 | Clinical Trials

​ Conditions: Atopic Dermatitis; Atopic; Dermatitis; AD; Eczema Interventions: Drug: ATI-045; Drug: Placebo Sponsors: Aclaris Therapeutics, Inc. Recruiting Conditions: Atopic Dermatitis; Atopic; Dermatitis; AD; Eczema Interventions: Drug: ATI-045; Drug: Placebo...

Muscle Injury RTP Design in Football; Effects of Backward Design vs Forward Design: A Randomized Controlled Trial

by palligoelme@gmail.com | Jun 10, 2025 | Clinical Trials

​ Conditions: Muscle Injuries; Football Players Interventions: Other: Return to play program with progressive design; Other: Return to play program with regressive design Sponsors: Universitat de les Illes Balears Not yet recruiting Conditions: Muscle Injuries;...

Staphylococcus Haemolyticus in the Neonatal Intensive Care Unit of CHSD in 2023: Analysis and Trends

by palligoelme@gmail.com | Jun 10, 2025 | Clinical Trials

​ Conditions: Staphylococcus Haemolyticus; Staphylococcal Infections; Sepsis; Catheter-Related Infections; Infant, Newborn; Intensive Care Units, Neonatal; Cross Infection; Drug Resistance, Bacterial Sponsors: Centre Hospitalier de Saint-Denis Completed Conditions:...
« Older Entries
Next Entries »

Recent Posts

  • Evaluation of Postoperative Pain After Using Resin-Based and Bioceramic Sealers in Mandibular Molars With Asymptomatic Apical Periodontitis
  • Multicenter Clinical Study on Robotic-Assisted Surgical Management of Posterior Cruciate Ligament Tibial Avulsion Fractures
  • A Wearable Sensor Platform for Remote Monitoring of Individuals on the Frontotemporal Dementia Spectrum
  • FirST Lines of Biologics in pAtients With ulceRaTivE Colitis: a Randomised Controlled Trial
  • Reestablishing Normal Gut-brain Interaction in Anorexia Nervose With Normal Gut Microbiota

Recent Comments

No comments to show.

Curasafe healthcare solutions Pvt. Ltd. provides comprehensive services including safety program oversight, risk management, and regulatory compliance.

Important Links

  • Home
  • Contact Us
Connect With Us

Contact


711, Shivalik Satyamev, Bopal Ambli Junction, Bopal, Ahmedabad, Daskroi, Gujarat, India, 380058.


info@curasafehealthcare.com



(+91) 97803 81065

Copyright © 2025 Curasafehealthcare ®